3-MMC, also known as 3-Methylmethcathinone (IUPAC: 2-(methylamino)-1-(3-methylphenyl)-1-propanone), is a synthetic cathinone belonging to the β-keto amphetamine class. It is structurally related to mephedrone (4-MMC) and methcathinone, differing by the position of the methyl group on the aromatic ring. The substance typically appears as a white to off-white crystalline powder and is most commonly encountered in salt form.
Pharmacological Profile:
3-MMC acts as a central nervous system stimulant and is reported to influence monoamine neurotransmitters, primarily dopamine, norepinephrine, and serotonin, through reuptake inhibition and release mechanisms. These properties account for stimulant-like and entactogenic effects observed in non-clinical reports. The compound has no approved medical or therapeutic application.
Health and Regulatory Considerations:
Scientific data on long-term toxicity are limited; however, available evidence indicates risks typical of synthetic cathinones, including cardiovascular stress, neurotoxicity, hyperthermia, and psychological disturbances. Due to its abuse potential and associated harms, 3-MMC is classified as a controlled substance or subject to strict regulation in many countries.
